Brief: Ryvu Therapeutics Appoints Vatnak VAT-Ho As Chief Business Officer
26/04/2021 14:10
April 26 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* RYVU THERAPEUTICS APPOINTS VATNAK VAT-HO AS CHIEF BUSINESS
OFFICER
Source text for Eikon: ID:nPn4fVKwga
Further company coverage: RVU.WA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project